Susceptibility testing of Aspergillus flavus: inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo
- PMID: 11302810
- PMCID: PMC90488
- DOI: 10.1128/AAC.45.5.1456-1462.2001
Susceptibility testing of Aspergillus flavus: inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo
Abstract
We have attempted to validate in Aspergillus flavus the main in vitro methodologies that have been used to detect resistance in Aspergillus fumigatus. We developed a murine model with two A. flavus isolates, one that was apparently resistant in vitro to amphotericin B (AFL5) and another that was resistant to itraconazole (AFL8). No correlation was found for amphotericin B in AFL5, since the in vivo response was compatible with a susceptible isolate. Modification of the in vitro susceptibility test methodology for amphotericin B was unsuccessful. Although AFL8 was apparently resistant to itraconazole in vitro, it was found to be susceptible in vivo. Additional in vitro work has detected weaknesses in the in vitro susceptibility methodology validated for A. fumigatus when applied to A. flavus. The principal problems are that changes in the inoculum have a large effect on the MICs of itraconazole for some A. flavus strains and that a trailing end point and spore sediment often appear when an inoculum with a higher colony count is used. We propose a modified method using a final inoculum of 2.5 x 10(4) CFU per ml of RPMI 1640 medium with 2% glucose buffered to pH 7.0 in a microtiter format, incubated for 48 h with no growth end point. Validation of this methodology requires one or more itraconazole-resistant A. flavus isolates, which have yet to be identified.
Figures



Similar articles
-
Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.J Antimicrob Chemother. 2003 Nov;52(5):873-6. doi: 10.1093/jac/dkg434. Epub 2003 Sep 30. J Antimicrob Chemother. 2003. PMID: 14519673
-
Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.J Clin Microbiol. 1995 May;33(5):1302-7. doi: 10.1128/jcm.33.5.1302-1307.1995. J Clin Microbiol. 1995. PMID: 7615745 Free PMC article.
-
In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus.J Med Microbiol. 1999 Dec;48(12):1087-1093. doi: 10.1099/00222615-48-12-1087. J Med Microbiol. 1999. PMID: 10591162
-
Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.Vet Rec. 2006 Aug 26;159(9):282-4. doi: 10.1136/vr.159.9.282. Vet Rec. 2006. PMID: 16946311
-
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).Clin Microbiol Infect. 2020 Nov;26(11):1464-1472. doi: 10.1016/j.cmi.2020.06.007. Epub 2020 Jun 17. Clin Microbiol Infect. 2020. PMID: 32562861 Review.
Cited by
-
Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.Front Microbiol. 2017 May 16;8:841. doi: 10.3389/fmicb.2017.00841. eCollection 2017. Front Microbiol. 2017. PMID: 28559881 Free PMC article. Review.
-
Azole cross-resistance in Aspergillus fumigatus.Antimicrob Agents Chemother. 2002 Feb;46(2):556-7. doi: 10.1128/AAC.46.2.556-557.2002. Antimicrob Agents Chemother. 2002. PMID: 11796377 Free PMC article.
-
Animal Models of Aspergillosis.Comp Med. 2018 Apr 2;68(2):109-123. Comp Med. 2018. PMID: 29663936 Free PMC article. Review.
-
The high efficacy of luliconazole against environmental and otomycosis Aspergillus flavus strains.Iran J Microbiol. 2020 Apr;12(2):170-176. Iran J Microbiol. 2020. PMID: 32494352 Free PMC article.
-
Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum.Antimicrob Agents Chemother. 2013 Apr;57(4):1625-31. doi: 10.1128/AAC.01573-12. Epub 2013 Jan 14. Antimicrob Agents Chemother. 2013. PMID: 23318807 Free PMC article.
References
-
- Denning D W. Invasive aspergillosis in immunocompromised patients. Curr Opin Infect Dis. 1994;7:456–462.
-
- Denning D W. Invasive aspergillosis. Clin Infect Dis. 1998;26:781–805. - PubMed
-
- Denning D W, Baily G G, Hood S V. Azole resistance in Candida. Eur J Clin Microbiol Infect Dis. 1997;16:1–20. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical